Low-dose aspirin use does not increase survival in 2 independent population-based cohorts of patients with esophageal or gastric cancer
Gastroenterology Nov 10, 2017
Spence AD, et al. - Two large cohorts were studied to ascertain the relationship between aspirin use and cancer-specific mortality in patients with esophageal or gastric cancer. In the current study, no association was demonstrated between low-dose aspirin use and increased survival of patients diagnosed with esophageal or gastric cancer.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
